Oramed Pharmaceuticals Inc (ORMP)
2.305
-0.02
(-1.07%)
USD |
NASDAQ |
May 17, 16:00
2.305
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals Cash from Operations (Quarterly): -1.476M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.476M |
| December 31, 2023 | -1.418M |
| September 30, 2023 | -0.694M |
| June 30, 2023 | -2.634M |
| March 31, 2023 | -5.549M |
| December 31, 2022 | -8.062M |
| September 30, 2022 | -2.241M |
| June 30, 2022 | -8.49M |
| March 31, 2022 | -9.125M |
| November 30, 2021 | -6.903M |
| August 31, 2021 | -6.142M |
| May 31, 2021 | -5.638M |
| February 28, 2021 | -3.249M |
| November 30, 2020 | -6.152M |
| August 31, 2020 | -2.458M |
| May 31, 2020 | -3.357M |
| February 29, 2020 | -3.629M |
| November 30, 2019 | -2.996M |
| August 31, 2019 | -3.268M |
| May 31, 2019 | -3.657M |
| February 28, 2019 | -1.884M |
| November 30, 2018 | -4.131M |
| August 31, 2018 | -4.648M |
| May 31, 2018 | -3.805M |
| February 28, 2018 | -3.476M |
| Date | Value |
|---|---|
| November 30, 2017 | -2.728M |
| August 31, 2017 | -2.048M |
| May 31, 2017 | -2.356M |
| February 28, 2017 | -2.925M |
| November 30, 2016 | 1.498M |
| August 31, 2016 | 6.803M |
| May 31, 2016 | -2.225M |
| February 29, 2016 | 2.324M |
| November 30, 2015 | -2.247M |
| August 31, 2015 | -1.029M |
| May 31, 2015 | -0.914M |
| February 28, 2015 | -1.604M |
| November 30, 2014 | -1.399M |
| August 31, 2014 | -0.802M |
| May 31, 2014 | -1.036M |
| February 28, 2014 | -1.482M |
| November 30, 2013 | -0.748M |
| August 31, 2013 | -0.2808M |
| May 31, 2013 | -1.050M |
| February 28, 2013 | -1.273M |
| November 30, 2012 | -0.7928M |
| August 31, 2012 | -0.3417M |
| May 31, 2012 | -0.8837M |
| February 29, 2012 | -0.5915M |
| November 30, 2011 | -0.4841M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-9.125M
Minimum
Mar 2022
-0.694M
Maximum
Sep 2023
-4.357M
Average
-3.493M
Median
Cash from Operations (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 29.08M |
| Cassava Sciences Inc | -19.13M |
| Vertex Pharmaceuticals Inc | 1.307B |
| Cormedix Inc | -17.31M |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 30.00M |
| Cash from Financing (Quarterly) | -19.00M |
| Free Cash Flow | -6.279M |
| Free Cash Flow Per Share (Quarterly) | -0.0356 |
| Free Cash Flow Yield | -6.65% |